{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:07:20Z","timestamp":1790406440386,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1208\/s12249-020-01877-9","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T18:02:31Z","timestamp":1606327351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Shear-Thinning Viscous Materials for Subconjunctival Injection of Microparticles"],"prefix":"10.1208","volume":"22","author":[{"given":"Shiyu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"issue":"2","key":"1877_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","volume":"27","author":"I Bahar","year":"2008","unstructured":"Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A. Subconjunctival bevacizumab injection for corneal neovascularization. Cornea. 2008;27(2):142\u20137.","journal-title":"Cornea."},{"issue":"10","key":"1877_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/ICO.0000000000000899","volume":"35","author":"JC Tan","year":"2016","unstructured":"Tan JC, Mann S, Coroneo MT. Successful treatment of conjunctival lymphangiectasia with subconjunctival injection of bevacizumab. Cornea. 2016;35(10):1375\u20137.","journal-title":"Cornea."},{"issue":"11","key":"1877_CR3","first-page":"20271","volume":"8","author":"Q Xu","year":"2015","unstructured":"Xu Q, Tan X, Zhang Y, Jie Y, Pan Z. Subconjunctival injection of in vitro transforming growth factor-beta-induced regulatory T cells prolongs allogeneic corneal graft survival in mice. Int J Clin Exp Med. 2015;8(11):20271\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"1877_CR4","doi-asserted-by":"publisher","first-page":"137136","DOI":"10.1155\/2015\/137136","volume":"2015","author":"J Yoshida","year":"2015","unstructured":"Yoshida J, Wicks RT, Zambrano AI, Tyler BM, Javaherian K, Grossman R, et al. Inhibition of corneal neovascularization by subconjunctival injection of Fc-endostatin, a novel inhibitor of angiogenesis. J Ophthalmol. 2015;2015:137136.","journal-title":"J Ophthalmol"},{"key":"1877_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.nano.2019.01.001","volume":"17","author":"B Wang","year":"2019","unstructured":"Wang B, Tang Y, Oh Y, Lamb NW, Xia S, Ding Z, et al. Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization. Nanomedicine. 2019;17:119\u201323.","journal-title":"Nanomedicine."},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.018","volume":"296","author":"L Luo","year":"2019","unstructured":"Luo L, Yang J, Oh Y, Hartsock MJ, Xia S, Kim YC, et al. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. J Control Release. 2019;296:68\u201380.","journal-title":"J Control Release"},{"issue":"3","key":"1877_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348\u201360.","journal-title":"AAPS J"},{"issue":"1","key":"1877_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0974-9233.106384","volume":"20","author":"Q Xu","year":"2013","unstructured":"Xu Q, Kambhampati SP, Kannan RM. Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol. 2013;20(1):26\u201337.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"1877_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/bjo.87.4.436","volume":"87","author":"A Lux","year":"2003","unstructured":"Lux A, Maier S, Dinslage S, Suverkrup R, Diestelhorst M. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate. Br J Ophthalmol. 2003;87(4):436\u201340.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1877_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0002-9394(14)75953-7","volume":"85","author":"TF Patton","year":"1978","unstructured":"Patton TF, Francoeur M. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Am J Ophthalmol. 1978;85(2):225\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1877_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3129\/i08-076","volume":"43","author":"R Kholdebarin","year":"2008","unstructured":"Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43(4):454\u201361.","journal-title":"Can J Ophthalmol"},{"issue":"3\u20134","key":"1877_CR12","first-page":"135","volume":"13","author":"EM Del Amo","year":"2008","unstructured":"Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today. 2008;13(3\u20134):135\u201343.","journal-title":"Drug Discov Today"},{"issue":"1\u20132","key":"1877_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijpharm.2012.05.025","volume":"434","author":"RS Kadam","year":"2012","unstructured":"Kadam RS, Tyagi P, Edelhauser HF, Kompella UB. Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm. 2012;434(1\u20132):140\u20137.","journal-title":"Int J Pharm"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jconrel.2015.01.009","volume":"201","author":"Q Pan","year":"2015","unstructured":"Pan Q, Xu Q, Boylan NJ, Lamb NW, Emmert DG, Yang JC, et al. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. J Control Release. 2015;201:32\u201340.","journal-title":"J Control Release"},{"issue":"2","key":"1877_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47\u201364.","journal-title":"World J Pharmacol"},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s10792-020-01391-8","volume":"40","author":"F Rafiei","year":"2020","unstructured":"Rafiei F, Tabesh H, Farzad F. Sustained subconjunctival drug delivery systems: current trends and future perspectives. Int Ophthalmol. 2020;40:2385\u2013401.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"1877_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","volume":"28","author":"MS Shive","year":"1997","unstructured":"Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5\u201324.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"1877_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3109\/02652048.2014.944949","volume":"32","author":"S Alipour","year":"2015","unstructured":"Alipour S, Montaseri H, Tafaghodi M. Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization. J Microencapsul. 2015;32(7):661\u20138.","journal-title":"J Microencapsul"},{"issue":"7","key":"1877_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/molecules21070873","volume":"21","author":"MP Costa","year":"2016","unstructured":"Costa MP, Feitosa AC, Oliveira FC, Cavalcanti BC, da Silva EN, Dias GG, et al. Controlled release of nor-beta-lapachone by PLGA microparticles: a strategy for improving cytotoxicity against prostate cancer cells. Molecules. 2016;21(7):873.","journal-title":"Molecules."},{"key":"1877_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.msec.2016.04.071","volume":"66","author":"JD Obayemi","year":"2016","unstructured":"Obayemi JD, Danyuo Y, Dozie-Nwachukwu S, Odusanya OS, Anuku N, Malatesta K, et al. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: effects of particle size on drug release kinetics and cell viability. Mater Sci Eng C Mater Biol Appl. 2016;66:51\u201365.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"1877_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/bit.21301","volume":"96","author":"DS Kohane","year":"2007","unstructured":"Kohane DS. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng. 2007;96(2):203\u20139.","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"1877_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1167\/iovs.05-0531","volume":"47","author":"AC Amrite","year":"2006","unstructured":"Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci. 2006;47(3):1149\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1877_CR23","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1167\/iovs.02-0791","volume":"44","author":"UB Kompella","year":"2003","unstructured":"Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci. 2003;44(3):1192\u2013201.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1877_CR24","first-page":"1163","volume":"7","author":"B Tarlan","year":"2013","unstructured":"Tarlan B, Kiratli H. Subconjunctival hemorrhage: risk factors and potential indicators. Clin Ophthalmol. 2013;7:1163\u201370.","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"1877_CR25","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.biomaterials.2009.12.004","volume":"31","author":"BG Ballios","year":"2010","unstructured":"Ballios BG, Cooke MJ, van der Kooy D, Shoichet MS. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases. Biomaterials. 2010;31(9):2555\u201364.","journal-title":"Biomaterials."},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jconrel.2015.09.065","volume":"219","author":"V Delplace","year":"2015","unstructured":"Delplace V, Payne S, Shoichet M. Delivery strategies for treatment of age-related ocular diseases: from a biological understanding to biomaterial solutions. J Control Release. 2015;219:652\u201368.","journal-title":"J Control Release"},{"issue":"2","key":"1877_CR27","first-page":"137","volume":"81","author":"H Cronau","year":"2010","unstructured":"Cronau H, Kankanala RR, Mauger T. Diagnosis and management of red eye in primary care. Am Fam Physician. 2010;81(2):137\u201344.","journal-title":"Am Fam Physician"},{"issue":"7","key":"1877_CR28","first-page":"525","volume":"18","author":"DB Reed","year":"1987","unstructured":"Reed DB, Mannis MJ, Hills JF, Johnson CA. Corneal epithelial healing after penetrating keratoplasty using topical Healon versus balanced salt solution. Ophthalmic Surg. 1987;18(7):525\u20138.","journal-title":"Ophthalmic Surg"},{"issue":"1","key":"1877_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41467-020-14340-x","volume":"11","author":"H Tsujinaka","year":"2020","unstructured":"Tsujinaka H, Fu J, Shen J, Yu Y, Hafiz Z, Kays J, et al. Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles. Nat Commun. 2020;11(1):694.","journal-title":"Nat Commun"},{"key":"1877_CR30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jconrel.2020.08.019","volume":"327","author":"J Yang","year":"2020","unstructured":"Yang J, Luo L, Oh Y, Meng T, Chai G, Xia S, et al. Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats. J Control Release. 2020;327:456\u201366.","journal-title":"J Control Release"},{"issue":"2","key":"1877_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jconrel.2004.07.007","volume":"99","author":"ID Rosca","year":"2004","unstructured":"Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release. 2004;99(2):271\u201380.","journal-title":"J Control Release"},{"key":"1877_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/OPTH.S13773","volume":"5","author":"U Benelli","year":"2011","unstructured":"Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011;5:783\u201390.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1877_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0975-1483.63144","volume":"2","author":"D Shastri","year":"2010","unstructured":"Shastri D, Patel L, Parikh R. Studies on in situ hydrogel: a smart way for safe and sustained ocular drug delivery. J Young Pharm. 2010;2(2):116\u201320.","journal-title":"J Young Pharm"},{"issue":"3","key":"1877_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1600-0420.1996.tb00088.x","volume":"74","author":"S Johansen","year":"1996","unstructured":"Johansen S, Rask-Pedersen E, Prause JU. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension. Acta Ophthalmol Scand. 1996;74(3):259\u201364.","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"1877_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0002-9394(99)80151-2","volume":"125","author":"S Shimmura","year":"1998","unstructured":"Shimmura S, Goto E, Shimazaki J, Tsubota K. Viscosity-dependent fluid dynamics of eyedrops on the ocular surface. Am J Ophthalmol. 1998;125(3):386\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1877_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1021\/bm049508a","volume":"6","author":"JA Burdick","year":"2005","unstructured":"Burdick JA, Chung C, Jia X, Randolph MA, Langer R. Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules. 2005;6(1):386\u201391.","journal-title":"Biomacromolecules."},{"issue":"1","key":"1877_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12896-014-0113-9","volume":"14","author":"L von Schantz","year":"2014","unstructured":"von Schantz L, Schagerl\u00f6f H, Karlsson EN, Ohlin M. Characterization of the substitution pattern of cellulose derivatives using carbohydrate-binding modules. BMC Biotechnol. 2014;14(1):1.","journal-title":"BMC Biotechnol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01877-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T10:04:11Z","timestamp":1623751451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01877-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01877-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"8"}}